Coronary

View the latest content related to this topic

One in Three Hospitalizations After Acute MI Go Unreported

The high rates of underreporting found across the board raise questions about research that relies on self-reported data.

L.A. McKeown

July 03, 2020

Slides

See all

Presentation

SCAI 2020

Reduction of Revascularization in Patients with Hypertriglyceridemia with Icosapent Ethyl: Insights from REDUCE-IT REVASC

Presenter: Benjamin E. Peterson

May 21, 2020

Presentation

SCAI 2020

Outcomes with Intermediate Left Main Disease on Coronary CT Angiography ISCHEMIA Intermediate LM Substudy

Presenter: Sripal Bangalore

May 16, 2020

Presentation

ACC 2020

EPA Levels and Cardiovascular Outcomes in the Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial

Presenter: Deepak L. Bhatt

March 30, 2020

Presentation

ACC 2020

Ticagrelor With or Without Aspirin in Acute Coronary Syndrome After PCI: Randomized Evaluation Of Ticagrelor Monotherapy After 3- month Dual-antiplatelet Therapy In Acute Coronary Syndrome The TICO trial

Presenter: Yangsoo Jang

March 30, 2020

Presentation

ACC 2020

Mental Stress-Induced Myocardial Ischemia as a Marker for Adverse Cardiovascular Events After MI

Presenter: Zakaria Almuwaqqat

March 30, 2020

News

See all

News

Troponin Testing in COVID-19: New Review Offers a Framework for Use

By Todd Neale

July 10, 2020

News

Smoking Still Common, Tied to Higher Mortality in Young MI Patients

By Yael L. Maxwell

July 09, 2020

News • Interventional

STEMI Spectrum in COVID-19 Captured by Multinational Case Series

By Caitlin E. Cox

July 08, 2020

News • Interventional

Complete Revascularization May Top Culprit-Only PCI Across ACS Types

By Todd Neale

July 08, 2020

News • Interventional

Polymer-Free DES Hold No Long-term Advantage: ISAR-TEST-5

By Michael O'Riordan

July 07, 2020

TCT 2020

October 14

October 18, 2020

TCT 2020 Call For Science

October 14

October 18, 2020

CTO 2020

February 19

February 21, 2020

TCT 2019

September 25

September 29, 2019

Videos on This Topic

See all

Topical Discussion

Advertisement

Coronary

One in Three Hospitalizations After Acute MI Go Unreported

Slides

Reduction of Revascularization in Patients with Hypertriglyceridemia with Icosapent Ethyl: Insights from REDUCE-IT REVASC

Outcomes with Intermediate Left Main Disease on Coronary CT Angiography ISCHEMIA Intermediate LM Substudy

EPA Levels and Cardiovascular Outcomes in the Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial

Ticagrelor With or Without Aspirin in Acute Coronary Syndrome After PCI: Randomized Evaluation Of Ticagrelor Monotherapy After 3- month Dual-antiplatelet Therapy In Acute Coronary Syndrome The TICO trial

Mental Stress-Induced Myocardial Ischemia as a Marker for Adverse Cardiovascular Events After MI

News

Troponin Testing in COVID-19: New Review Offers a Framework for Use

Smoking Still Common, Tied to Higher Mortality in Young MI Patients

STEMI Spectrum in COVID-19 Captured by Multinational Case Series

Complete Revascularization May Top Culprit-Only PCI Across ACS Types

Polymer-Free DES Hold No Long-term Advantage: ISAR-TEST-5

More on This Topic

Upcoming Conferences

TCT 2020

TCT 2020 Call For Science

Conference Coverage

CTO 2020

TCT 2019

Videos on This Topic

Cardiac Injury in COVID-19 Patients

Advertisement

Advertisement

Coronary

Slides

News

More on This Topic

Upcoming Conferences

Conference Coverage

Videos on This Topic

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content